Charles A. McWherter
2012
In 2012, Charles A. McWherter earned a total compensation of $352.5K as Senior Vice President and Chief Scientific Officer at Cymabay Therapeutics.
Compensation breakdown
| Option Awards | $11,400 |
|---|---|
| Salary | $327,309 |
| Other | $13,755 |
| Total | $352,464 |
McWherter received $327.3K in salary, accounting for 93% of the total pay in 2012.
McWherter also received $11.4K in option awards and $13.8K in other compensation.
Rankings
In 2012, Charles A. McWherter's compensation ranked 9,729th out of 11,487 executives tracked by ExecPay. In other words, McWherter earned more than 15.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,729 out of 11,487 | 15th |
Division Manufacturing | 3,613 out of 4,253 | 15th |
Major group Chemicals And Allied Products | 1,001 out of 1,198 | 16th |
Industry group Drugs | 756 out of 920 | 18th |
Industry Pharmaceutical Preparations | 583 out of 700 | 17th |
Source: SEC filing on April 21, 2014.
McWherter's colleagues
We found one more compensation record of an executive who worked with Charles A. McWherter at Cymabay Therapeutics in 2012.
2012
Harold Van Wart
Cymabay Therapeutics
Chief Executive Officer
News
Cymabay Therapeutics CEO Sujal Shah's 2022 pay rises 16% to $2.6M
April 19, 2023
Cymabay Therapeutics CEO Sujal Shah's 2021 pay slips 16% to $2.2M
April 26, 2022
Cymabay Therapeutics CEO Sujal Shah's 2019 pay jumps 32% to $2.6M
May 15, 2020
Cymabay Therapeutics General Counsel Paul Quinlan receives $3M in 2018
April 26, 2019